降血糖药物普兰林肽的固相合成

《降血糖药物普兰林肽的固相合成》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、中图分类号：R284.3编号：20090123承德医学院硕士研究生毕业论文降血糖药物普兰林肽的固相合成SolidphasesynthesisofPramlintide研究生：韩月导师：王良友副教授赵桂琴副教授学科专业：中药学所在系部：中药研究所研究起止日期：2010年9月～2012年3月论文提交日期：2012年3月承德医学院学位论文使用授权及知识产权归属承诺本学位论文在导师（或指导小组）的指导下，由本人独立完成。本学位论文研究所获的研究成果，其知识产权归承德医学院所有。承德医学院有权对本学位论文进行交流、公开和使用。凡发表与学位论文主要内容相关

2、的论文，第一署名单位为承德医学院，试验材料、原始数据、申报的专利等知识产权均归承德医学院所有。否则，承担相应的法律责任。研究生签名：导师签章：年月日承德医学院研究生学位论文独创性声明本论文是在导师指导下进行的研究工作及取得的研究成果，除了文中特别加以标注和致谢等内容外，文中不包含其他人已经发表或撰写的研究成果，指导教师对此进行了审定。本论文由本人独立撰写，文责自负。研究生签名：导师签章：年月日降血糖药物普兰林肽的固相合成SolidphasesynthesisofPramlintide研究生：韩月学号：20090123年级：2009级导师：王良友

3、副教授赵桂琴副教授学科专业：中药学所在系部：中药研究所研究方向：药物化学研究起止日期：2010年9月～2012年3月论文提交日期：2012年3月目录中文摘要···········································································································1英文摘要·····················································································

4、······················4英文缩写···········································································································7研究论文降血糖药物普兰林肽的固相合成前言···········································································································8材料与方法·······

5、························································································9结果··········································································································18附图··········································································

6、································23附表··········································································································36讨论··········································································································42结论···················

7、·······················································································43参考文献··································································································45综述················································································

8、··························47致谢·············································